Kuaishou IPO: Is It Worth Twice the IPO Price?
Kuaishou's grey market price has hit HK$250 per share, slightly more than 2x the IPO price of HK$115. Our analysis suggests that this valuation can...
426 Views
ECM Weekly (31 January 2021) - Kuaishou, Basecare Med, MicroPort Cardioflow, Cloopen
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
492 Views
Tencent: An Update on Investees and the Implied Valuation of Consolidated Operations
In this insight, I account for the increase in fair value of Tencent’s investees, including the Kuaishou IPO, which indicates that consolidated...
315 Views
Suzhou Basecare Medical IPO Valuation: Attractive Even at the Upper End of the IPO Pricing
Suzhou Basecare offers an innovative platform of genetic testing solutions for assisted reproduction in China In this insight, we examine the...
332 Views
Dida Pre-IPO - Peer Comparison - Lagging in Scale, Leading in Profitability
Dida (DIDA HK) (Dida), a technology driven mobility platform in China, aims to raise around US$400m in its Hong Kong IPO. The company is backed by...
289 Views